Sarepta Therapeutics, Inc. Message Board
-
ceo said mid year , june(6 month ) 1 month to scrub data from may
-
looks like u sold all your acad shares and went all in dcth, lol dcth is dead
-
-
gp..don't be so naive $$ talks, power makes the decision, look at the nsa snoopers and google with data collection
-
He said snts would not get its approval for uceris it was 11pps before its approval and its 22 after its approval...
-
cont. smart $$ getting out after a large jump fro 7s to 13s 1 1/2 ago
-
yesterday's action and today towards the end of each trading there was a big drop..
-
im in alot of bios. but last month i got into insm at mid 8s and it ran to 14s small float pending results due mid year.. I have been buying a ton of acad and kerx.. wish i got in on clvs and ran yesterday to mid 80s from 35s, great data presented at the asco Monday it will be on my watch list
-
just research his picks and you'll see what junk write up he does. Not saying tsrx is a pump and dump..what I'm saying is 1. he buys 2. writes a pump article (not needed with tsrx) 3. sells after making small change..
just do your own dd.. -
-
gsk just buys thrx as a whole.pipe dreams huh
- Reply to
A must read for anyone who owns or anticipates owning TSRO stock worth is in single digits
by roxettewish •Jun 3, 2013 7:13 PMthanks i will sell tommorow, thank you for your concern
- Reply to
George says reduce shares in TSRO tonight of the 4 competitors, TSRO drug is the least effective drug
by roxettewish •Jun 3, 2013 4:29 PMwas this russell george of the irs, lol you should have listened to brian nichols of the motley fool and pearson from sa..
-
-
been declining for a whole week
- Reply to
Why would anone want to risk selling their shares right now when
by nt1127 •May 24, 2013 3:46 PMits sell off, not good news its bad news. good luck
-
this news should move acad tommorow..
-
gala, thanks for the infor, doing some dd
-
doesn't roche have lucentis for dme
-
Anyone have any detail on how much money has been generated from the sales for Roche. Can alim compete with such a big pharma. I know the market for dme is good size. How does lluvien compare to lucentis head to head.. Not bashing looking for info. Can seem to get info frm roche